spacer
home > ict > winter 2020 > comparator sourcing in china: three key trends for a new decade
PUBLICATIONS
International Clinical Trials

Comparator Sourcing in China: Three Key Trends for a New Decade




On average, more than 11,000 people are diagnosed with cancer in China every day. That is almost eight patients per minute. Dietary changes, smoking habits, and other lifestyle factors are also adding significant disease burdens. Although more Western lifestyles combined with better overall health has the positive effect of life expectancies improving, associated lifestyle illnesses – such as diabetes, stroke, and heart disease – are on the rise. In only a few decades, China has undergone substantial economic changes, but not without significant additional health and cost burdens.

The changing disease profiles, along with the rapid economic growth in China, pose a challenge for the healthcare system and has increased the demand for new and more complex treatments. Both global pharmaceutical companies and local manufacturers have caught up on this need, and one example of this is the large increase in the number of oncology trials being conducted in China.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
About the author


Viktor Sandstedt is an Account Executive at Inceptua, where he coordinates and leads clinical trials supply sourcing projects for the Chinese market. With over eight years of experience in China, Viktor is an expert at bridging cultural gaps for western companies in China. During his time at Inceptua, Viktor has worked together with leading global pharma companies and small/midsize biotechs. His main focus is securing reliable supplies to ensure patients wellbeing is not put at risk. Viktor is fluent in Swedish, English, and Mandarin.
viktor.sandstedt@inceptua.com
Print this page
Send to a friend
Privacy statement
News and Press Releases

Benchling Creates Open Source Library of Lab Instrument Data Converters

SAN FRANCISCO, May 16, 2023 — Benchling, the R&D Cloud powering the biotechnology industry, launched an initiative to standardize instrument data conversion in the scientific community today at the Bio-IT World Conference. The company's efforts are twofold: Benchling is contributing to industry standards as an active member of the Allotrope Foundation Partner Network (APN) and is also creating a library of open source converters that format instrument-generated data to the Allotrope Simple Model (ASM) standard to help organizations to put these standards into practice. By making these converters available in the open source, companies of all sizes will be able to easily standardize and connect instrument data within and across their labs, ultimately driving greater industry adoption of findable, accessible, interoperable, and reusable (FAIR) data.
More info >>

White Papers

Securing the Global Pharmaceutical Supply Chain against the Threat of Counterfeit Drugs

World Courier

With a fully integrated GxP-compliant transport, storage and distribution system in place and over 140 wholly owned ISO 9001 - certified offices in more than 50 countries, WORLD COURIER, an AmerisourceBergen® company, is the world’s largest and most experienced provider of specialty courier services. It is uniquely positioned to meet the most demanding industry requirements for managing the global distribution of time - and temperaturesensitive pharmaceutical products and IMPs used commercially or in clinical trials.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement